NEA Management Company as of Sept. 30, 2017
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 46.5 | $1.3B | 10M | 129.10 | |
| Mersana Therapeutics (MRSN) | 4.9 | $141M | 8.1M | 17.29 | |
| Epizyme | 4.3 | $123M | 6.5M | 19.05 | |
| Glycomimetics (GLYC) | 4.2 | $120M | 8.6M | 13.99 | |
| Senseonics Hldgs (SENS) | 3.7 | $107M | 33M | 3.19 | |
| Adaptimmune Therapeutics (ADAP) | 3.5 | $99M | 12M | 8.19 | |
| Dermira | 3.3 | $95M | 3.5M | 27.00 | |
| Achaogen | 2.9 | $83M | 5.2M | 15.95 | |
| Ardelyx (ARDX) | 2.8 | $79M | 14M | 5.60 | |
| Synlogic | 2.5 | $73M | 3.8M | 19.01 | |
| AVEO Pharmaceuticals | 2.1 | $60M | 16M | 3.65 | |
| Crispr Therapeutics (CRSP) | 2.0 | $58M | 3.2M | 17.87 | |
| Care | 1.8 | $52M | 3.3M | 15.89 | |
| Ra Pharmaceuticals | 1.8 | $51M | 3.5M | 14.60 | |
| Immunomedics | 1.4 | $39M | 2.8M | 13.98 | |
| Cascadian Therapeutics | 1.3 | $37M | 9.1M | 4.09 | |
| Clementia | 1.3 | $36M | 2.1M | 16.89 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $30M | 4.8M | 6.27 | |
| Lexicon Pharmaceuticals (LXRX) | 1.0 | $29M | 2.4M | 12.29 | |
| Strongbridge Bioph shs usd | 1.0 | $29M | 4.1M | 6.90 | |
| Obseva Sa | 0.9 | $27M | 3.3M | 8.14 | |
| Verona Pharma Plc ads (VRNA) | 0.7 | $19M | 1.2M | 15.35 | |
| Tintri Inc. equity | 0.6 | $17M | 5.3M | 3.14 | |
| Sucampo Pharmaceuticals | 0.5 | $15M | 1.3M | 11.80 | |
| Regulus Therapeutics | 0.5 | $14M | 11M | 1.25 | |
| Nightstar Therapeutics | 0.5 | $14M | 714k | 19.20 | |
| Endologix | 0.4 | $11M | 2.5M | 4.46 | |
| Trevena | 0.3 | $9.7M | 3.8M | 2.55 | |
| Affimed Therapeutics B V | 0.3 | $8.7M | 3.9M | 2.25 | |
| Tracon Pharmaceuticals | 0.3 | $8.7M | 2.8M | 3.15 | |
| Rigel Pharmaceuticals | 0.3 | $8.2M | 3.2M | 2.54 | |
| Proteostasis Therapeutics In | 0.3 | $7.5M | 3.6M | 2.10 | |
| Dasan Zhone Solutions | 0.2 | $6.5M | 956k | 6.83 | |
| Champions Oncology (CSBR) | 0.2 | $5.7M | 1.6M | 3.67 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $5.4M | 1.1M | 5.15 | |
| ArQule | 0.1 | $2.8M | 2.5M | 1.11 | |
| Akari Therapeutics | 0.1 | $2.8M | 452k | 6.14 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $2.5M | 1.3M | 1.94 | |
| Pixelworks (PXLW) | 0.1 | $1.7M | 360k | 4.71 | |
| Arca Biopharma | 0.1 | $1.7M | 1.5M | 1.15 | |
| Orexigen Therapeutics | 0.0 | $786k | 371k | 2.12 | |
| Cerecor | 0.0 | $506k | 595k | 0.85 | |
| Roka Bioscience | 0.0 | $652k | 894k | 0.73 | |
| Catalyst Biosciences | 0.0 | $220k | 44k | 5.06 |
